Associations of Abdominal and Cardiovascular Adipose Tissue Depots With HDL Metrics in Midlife Women: the SWAN Study.
abdominal visceral fat
cardiovascular fat
high-density lipoproteins
midlife women
Journal
The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362
Informations de publication
Date de publication:
17 05 2022
17 05 2022
Historique:
received:
29
11
2021
pubmed:
18
3
2022
medline:
20
5
2022
entrez:
17
3
2022
Statut:
ppublish
Résumé
The menopause transition is accompanied by declines in the atheroprotective features of high-density lipoprotein (HDL), which are linked to deleterious cardiovascular (CV) outcomes. This work aimed to assess the relationship between abdominal and CV visceral adipose tissues (VAT) with future HDL metrics in midlife women, and the role of insulin resistance (IR) on these associations. Temporal associations compared abdominal and CV fat with later measures of HDL metrics. This community-based cohort comprised 299 women, baseline mean age 51.1 years (SD: 2.8 years), 67% White, 33% Black, from the Study of Women's Health Across the Nation (SWAN) HDL ancillary study. Exposures included volumes of abdominal VAT, epicardial AT (EAT), paracardial AT (PAT), or perivascular AT (PVAT). Main outcomes included HDL cholesterol efflux capacity (HDL-CEC); HDL phospholipids (HDL-PL), triglycerides (HDL-Tgs), and cholesterol (HDL-C); apolipoprotein A-I (ApoA-I), and HDL particles (HDL-P) and size. In multivariable models, higher abdominal VAT was associated with lower HDL-CEC, HDL-PL, HDL-C, and large HDL-P and smaller HDL size. Higher PAT was associated with lower HDL-PL, HDL-C, and large HDL-P and smaller HDL size. Higher EAT was associated with higher small HDL-P. Higher PVAT volume was associated with lower HDL-CEC. The Homeostatic Model Assessment of Insulin Resistance partially mediated the associations between abdominal AT depots with HDL-CEC, HDL-C, large HDL-P, and HDL size; between PVAT with HDL-CEC; and PAT with HDL-C, large HDL-P, and HDL size. In midlife women, higher VAT volumes predict HDL metrics 2 years later in life, possibly linking them to future CV disease. Managing IR may preclude the unfavorable effect of visceral fat on HDL metrics.
Identifiants
pubmed: 35298649
pii: 6550277
doi: 10.1210/clinem/dgac148
pmc: PMC9113818
doi:
Substances chimiques
Cholesterol, HDL
0
Lipoproteins, HDL
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2245-e2257Subventions
Organisme : NIA NIH HHS
ID : U01 AG012539
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG012531
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG012554
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG012505
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG012546
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG012535
Pays : United States
Organisme : NIA NIH HHS
ID : U19 AG063720
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG012495
Pays : United States
Organisme : NINR NIH HHS
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG012553
Pays : United States
Organisme : NHLBI NIH HHS
ID : HL065581
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG017719
Pays : United States
Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
Int J Obes Relat Metab Disord. 2001 Jun;25(6):863-73
pubmed: 11439301
N Engl J Med. 2011 Jan 13;364(2):127-35
pubmed: 21226578
J Biol Chem. 2001 Feb 16;276(7):4804-11
pubmed: 11067853
Metabolism. 1986 Feb;35(2):99-104
pubmed: 3080655
Arterioscler Thromb Vasc Biol. 2001 Jan;21(1):13-27
pubmed: 11145929
Physiol Rev. 2013 Jan;93(1):359-404
pubmed: 23303913
Int J Obes. 1990 Dec;14(12):1013-22
pubmed: 2086494
Obesity (Silver Spring). 2015 Mar;23(3):602-7
pubmed: 25612068
Int J Obes Relat Metab Disord. 1996 Mar;20 Suppl 3:S114-20
pubmed: 8680471
Diabetes Care. 2000 Jan;23(1):57-63
pubmed: 10857969
Curr Opin Lipidol. 2017 Aug;28(4):328-336
pubmed: 28459707
J Clin Endocrinol Metab. 2022 May 17;107(6):e2245-e2257
pubmed: 35298649
J Clin Endocrinol Metab. 2017 Nov 1;102(11):4117-4123
pubmed: 28938424
Diabetes. 2008 Aug;57(8):2022-7
pubmed: 18469202
J Clin Endocrinol Metab. 2015 Sep;100(9):3304-12
pubmed: 26176800
Circulation. 2020 Dec 22;142(25):e506-e532
pubmed: 33251828
Clin Biochem. 2003 Sep;36(6):421-9
pubmed: 12951168
J Am Heart Assoc. 2017 Jan 29;6(2):
pubmed: 28137715
Obesity (Silver Spring). 2013 Sep;21(9):E439-47
pubmed: 23687099
Arterioscler Thromb Vasc Biol. 2010 Apr;30(4):796-801
pubmed: 20075420
Int J Obes (Lond). 2008 Jun;32(6):949-58
pubmed: 18332882
Menopause. 2008 May-Jun;15(3):429-34
pubmed: 18204407
J Lipid Res. 1978 Jan;19(1):65-76
pubmed: 202660
Atherosclerosis. 2012 Mar;221(1):198-205
pubmed: 22209479
Diabetes Care. 2003 May;26(5):1413-20
pubmed: 12716798
Drug Discov Ther. 2015 Dec;9(6):380-5
pubmed: 26781921
Obesity (Silver Spring). 2009 Mar;17(3):424-30
pubmed: 19219061
Med Sci Sports Exerc. 2000 Jul;32(7):1327-38
pubmed: 10912901
Diabetes Care. 1996 Apr;19(4):387-9
pubmed: 8729169
J Am Coll Cardiol. 2018 Feb 13;71(6):620-632
pubmed: 29420958
Biomedicines. 2021 Feb 27;9(3):
pubmed: 33673728
JAMA Cardiol. 2019 Aug 1;4(8):778-787
pubmed: 31268469
Proc Natl Acad Sci U S A. 1983 Mar;80(5):1449-53
pubmed: 6402780
Menopause. 2021 Mar 1;28(6):626-633
pubmed: 33651741
Arterioscler Thromb Vasc Biol. 2015 Jun;35(6):1515-9
pubmed: 25838421
J Am Coll Cardiol. 2009 Dec 15;54(25):2366-73
pubmed: 20082925
J Obes. 2019 Feb 3;2019:2107178
pubmed: 30863631
Circulation. 2013 Sep 10;128(11):1189-97
pubmed: 24002795
J Lipid Res. 2009 Feb;50(2):183-92
pubmed: 18787236
Physiol Res. 1998;47(6):387-97
pubmed: 10453745
Atherosclerosis. 2015 Aug;241(2):664-70
pubmed: 26117404
J Lipid Res. 1995 Mar;36(3):573-82
pubmed: 7775869
Menopause. 2018 Aug;25(8):849-854
pubmed: 30045364
Obesity (Silver Spring). 2007 Dec;15(12):2875-88
pubmed: 18198293
Clin Lab. 2003;49(11-12):601-13
pubmed: 14651331
Circulation. 2009 Feb 24;119(7):931-9
pubmed: 19204302
Int J Biochem Cell Biol. 2006 Mar;38(3):392-403
pubmed: 16288898
Arterioscler Thromb Vasc Biol. 2018 Sep;38(9):2236-2244
pubmed: 30026268
J Clin Endocrinol Metab. 1988 Feb;66(2):408-13
pubmed: 3339113
Obesity (Silver Spring). 2012 Aug;20(8):1572-6
pubmed: 22282049
Arterioscler Thromb Vasc Biol. 2021 Feb;41(2):951-961
pubmed: 33267661
J Am Coll Cardiol. 2008 Feb 12;51(6):634-42
pubmed: 18261682
Atherosclerosis. 2013 Nov;231(1):129-35
pubmed: 24125423
PLoS One. 2017 Feb 3;12(2):e0171293
pubmed: 28158227
Clin Lab Med. 2006 Dec;26(4):847-70
pubmed: 17110242
J Clin Endocrinol Metab. 2022 Jan 1;107(1):e303-e314
pubmed: 34390340
Int J Womens Health. 2010 Aug 09;1:181-91
pubmed: 21072287
Atherosclerosis. 2009 Oct;206(2):434-8
pubmed: 19376519
Diabetes Care. 2005 Sep;28(9):2181-6
pubmed: 16123487
Rev Port Cardiol (Engl Ed). 2019 Jun;38(6):419-423
pubmed: 31324408